Free public records show Medaica, Inc. in 13 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
1 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Markets we cover where free public records show Medaica, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Medaica, Inc. is in.
Stories on the topics Medaica, Inc. works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Read